DISSECTING THE DASATINIB-OME AND OPTIMIZING THERAPY DELIVERY TO ADDRESS CELLULAR PLASTICITY AND THERAPY RESISTANCE IN ACRAL MELANOMA

The Johns Hopkins University

Investigators